PMID: 2574731Dec 1, 1989

H1-receptor antagonists: clinical pharmacology and therapeutics

The Journal of Allergy and Clinical Immunology
F E Simons

Abstract

Each H1-receptor antagonist has unique pharmacokinetic and pharmacodynamic properties, and each H1-antagonist has unique potency and potential for causing adverse effects. Some of the first-generation H1-receptor antagonists should no longer be used because their relative lack of efficacy is combined with a high potential for causing adverse effects. Some of the new H1-receptor antagonists, in manufacturers' recommended doses, seldom cause sedation but may have only modest potency. The choice of optimal H1-receptor antagonist treatment for each patient should be based on up-to-date clinical pharmacology information.

References

Oct 1, 1993·Journal of Clinical Pharmacology·Y HorsmansC Harvengt
Jan 1, 1996·Journal of Clinical Pharmacology·J L PinquierP Rosenzweig
Apr 26, 2005·International Ophthalmology·James I McGill
Jul 5, 2001·European Journal of Pharmacology·A ImaiShigekatsu Kohno
Mar 1, 1997·Clinical Therapeutics·E W Monroe
Jan 13, 2001·Journal of Dermatological Science·M FurueT Koga
Apr 1, 1996·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·R B BerkowitzT Woehler
Jun 3, 1998·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·M Murris-EspinA Didier
Mar 1, 1997·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·J H ChungF M Baroody
May 1, 1997·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·E O MeltzerK Drda
Oct 1, 1996·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·R A Nathan
Nov 17, 1999·Clinical and Experimental Dermatology·D BayramgürlerT Utkan
Sep 19, 1991·The New England Journal of Medicine·R M Naclerio
Aug 1, 1990·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·S J Rimmer, M K Church
Aug 1, 1990·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·F E Simons
Mar 1, 1995·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·F A Bahmer
Dec 1, 1996·International Journal of Dermatology·E W Monroe
Nov 1, 1994·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·J Vermeulen, M Mercer
Jan 30, 1999·The British Journal of Ophthalmology·J I McGillA Bacon
Jun 5, 2001·Japanese Journal of Pharmacology·Takeshi NabeShigekatsu Kohno
Dec 1, 1990·The Journal of Allergy and Clinical Immunology·A L Sheffer, L L Samuels
Dec 1, 1990·The Journal of Allergy and Clinical Immunology·F E Simons
Mar 1, 1994·The Journal of Allergy and Clinical Immunology·M WagenmannR M Naclerio
Jul 1, 1991·The Journal of Allergy and Clinical Immunology·C AdvenierC De Vos
Apr 1, 1994·Contact Dermatitis·R ValsecchiT Cainelli
Aug 5, 2005·Journal of Pharmacological Sciences·Takeshi NabeShigekatsu Kohno
Nov 1, 1994·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·R Moulton-BarrettG Brauel
Feb 1, 1996·Annals of Medicine·J Suonpaa
Jan 15, 1991·Hospital Practice·D B Engler, J A Grant
Jan 1, 1993·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·N I Kjellman

Citations

Nov 14, 1977·European Journal of Clinical Pharmacology·K J HütherJ Koch-Weser
Feb 1, 1988·The Journal of Allergy and Clinical Immunology·M BadierJ Orehek
Feb 1, 1989·The Journal of Allergy and Clinical Immunology·S S LuskinA T Luskin
Oct 1, 1989·The Journal of Allergy and Clinical Immunology·W T WatsonF E Simons
Sep 1, 1989·Journal of Clinical Pharmacology·F E SimonsK J Simons
Aug 1, 1985·The Journal of Allergy and Clinical Immunology·S T HolgateP H Howarth
Mar 8, 1986·British Medical Journal·T M Craft
Jan 1, 1986·European Journal of Clinical Pharmacology·E Paul, R H Bödeker
Feb 1, 1987·The Journal of Allergy and Clinical Immunology·K R Patel
Jan 1, 1987·International Archives of Allergy and Applied Immunology·A PécoudM Kolly
Jun 1, 1987·The Journal of Allergy and Clinical Immunology·K J Simons, F E Simons
Jul 1, 1987·The Journal of Allergy and Clinical Immunology·T RothF Zorick
Jan 1, 1987·European Journal of Clinical Pharmacology·C M Bradley, A N Nicholson
Oct 1, 1986·British Journal of Diseases of the Chest·T B ChanN M Eiser
Dec 1, 1987·The Journal of Allergy and Clinical Immunology·F E SimonsK J Simons
Jan 1, 1988·Clinical Allergy·H K RökenesH Rundcrantz
Jan 1, 1988·European Journal of Clinical Pharmacology·S A Henauer, U Glück
Jul 1, 1988·The British Journal of Dermatology·L Juhlin, C Arendt
Sep 10, 1988·Lancet·F E SimonsK J Simons
Dec 1, 1988·The Journal of Allergy and Clinical Immunology·F E SimonsK J Simons
Sep 1, 1987·Journal of Clinical Pharmacology·J HilbertN Zampaglione
Mar 1, 1988·Journal of Clinical Pharmacology·J HilbertN Zampaglione
Jan 1, 1988·European Journal of Clinical Pharmacology·M DomsJ P Rihoux
Jan 1, 1988·European Journal of Clinical Pharmacology·A W GaillardR de Jong
May 14, 1987·Nature·J M ArrangJ C Schwartz
Jan 1, 1986·The Journal of Allergy and Clinical Immunology·I L Bernstein, D I Bernstein
Feb 1, 1986·The Journal of Allergy and Clinical Immunology·L Gendreau-ReidF E Simons
Dec 1, 1986·The Journal of Allergy and Clinical Immunology·R W FoxD Serbousek
Mar 1, 1988·The Journal of Allergy and Clinical Immunology·J A GrantJ E Stroh
Oct 1, 1988·The British Journal of Dermatology·L ShallR Marks
Nov 1, 1988·Allergy Proceedings : the Official Journal of Regional and State Allergy Societies·M A Kaliner, W A Check
Jun 1, 1987·The Journal of Allergy and Clinical Immunology·J P KempJ L Perhach
Sep 1, 1987·The American Review of Respiratory Disease·M J GaffeyF G Hayden
Jun 1, 1986·The Journal of Pediatrics·F Filloux
Jul 1, 1986·The American Journal of Emergency Medicine·J JonesL Cannon

Related Concepts

Drug Tolerance
Antagonist Muscle Action
Clinical Pharmacology Discipline
Adverse Effects
Antihistamines, Classical
Upper Respiratory Infections
Drug Interactions
Pharmacodynamics
Drug Toxicity
Allergic Reaction

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Synapse Loss as Therapeutic Target in MS

As we age, the number of synapses present in the human brain starts to decline, but in neurodegenerative diseases this occurs at an accelerated rate. In MS, it has been shown that there is a reduction in synaptic density, which presents a potential target for treatment. Here is the latest research on synapse loss as a therapeutic target in MS.

Artificial Intelligence in Cardiac Imaging

Artificial intelligence (ai) techniques are increasingly applied to cardiovascular (cv) medicine in cardiac imaging analysis. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

Social Learning

Social learning involves learning new behaviors through observation, imitation and modeling. Follow this feed to stay up to date on the latest research.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Single Cell Chromatin Profiling

Techniques like ATAC-seq and CUT&Tag have the potential to allow single cell profiling of chromatin accessibility, histones, and TFs. This will provide novel insight into cellular heterogeneity and cell states. Discover the latest research on single cell chromatin profiling here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells.

Related Papers

The New England Journal of Medicine
R M Naclerio
Allergy Proceedings : the Official Journal of Regional and State Allergy Societies
M A Kaliner, W A Check
© 2020 Meta ULC. All rights reserved